2 news items
Class Action Against Abbott's Glucerna Products Proceeds in Federal Court
ABT
7 Jun 24
(NYSE:ABT) regarding its Glucerna shakes and nutritional powders.
The lawsuit claims these products
Jim Cramer Calls This Healthcare Stock A 'Worthy Spec,' Recommends Avoiding Canada Goose
ABT
BROS
GOOS
21 May 24
-year revenue guidance.
“The outlook is fabulous. There is a lawsuit in July that, involving formula,” Cramer said when asked
- Prev
- 1
- Next